News
JP Morgan Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $27
12 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $44 Price Target
7 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: ITeos Therapeutics Q4 Earnings
6 Mar 24
Earnings
ITeos Therapeutics Q4 EPS $(0.85) Beats $(1.03) Estimate, Cash and Investment Position Of $632.7M Is Expected To Provide Cash Runway Through 2026
6 Mar 24
Earnings, News
iTeos To Highlight Preclinical Data On First-In-Class EOS-984 Targeting ENT1 At The American Association For Cancer Research Annual Meeting 2024
5 Mar 24
Biotech, News, General
Press releases
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
7 Apr 24
Health Care, Press Releases
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
6 Mar 24
News, Management, Press Releases
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
5 Mar 24
News, Health Care, Press Releases
iTeos to Participate in Upcoming Investor Conferences
1 Mar 24
News, Press Releases